Journal article
The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer
AB Spurdle, B Goodwin, E Hodgson, JL Hopper, XQ Chen, DM Purdie, MRE McCredie, GG Giles, G Chenevix-Trench, C Liddle
Pharmacogenetics | LIPPINCOTT WILLIAMS & WILKINS | Published : 2002